Imiquimod Size:Solid 2 mg InChi: InChI=1S/C22H30O2S/c1-17(2)9-7-10-18(3)11-8-12-19(4)15-16-25-21-14-6-5-13-20(21)22(23)24/h5-6

InChi: InChI=1S/C22H30O2S/c1-17(2)9-7-10-18(3)11-8-12-19(4)15-16-25-21-14-6-5-13-20(21)22(23)24/h5-6

InChi: InChI=1S/C59H79N15O21S6/c1-26-47(82)69-41-25-101-99-22-38-52(87)65-33(13-14-45(80)81)49(84)66-34(16-28-5-9-30(76)10-6-28)50(85)71-40(54(89)72-39(23-97-96-20-32(60)48(83)70-38)53(88)67-35(18-43(61)78)58(93)74-15-3-4-42(74)56(91)63-26)24-100-98-21-37(64-44(79)19-62-57(92)46(27(2)75)73-55(41)90)51(86)68-36(59(94)95)17-29-7-11-31(77)12-8-29/h5-12

while it failed to displace [(3)H]LY341495 (a competitive mGlu2/3 receptor antagonist)

6]naphthyridine-8-carboxylic acid (CX-4945)

CAS Number: 90332-66-4

Imiquimod Size:Solid 2 mg InChi: InChI=1S/C22H30O2S/c1-17(2)9-7-10-18(3)11-8-12-19(4)15-16-25-21-14-6-5-13-20(21)22(23)24/h5-6Imiquimod is a prescription medication that acts as an immune response modifier. Imiquimod signals to the innate arm of the immune system through the toll like receptor 7 (TLR7), commonly involved in pathogen recognition. Cells activated by imiquimod via TLR 7 secrete cytokines (primarily interferon (INF ), interleukin 6 (IL 6), and tumor necrosis factor (TNF )). Imiquimod, when applied to skin, can lead to the activation of Langerhans cells, which